We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Agilent Technologies Announces Expanded Use of Cancer Diagnostic in Europe

Product News   Jun 19, 2017 | Original story from Agilent

 
Agilent Technologies Announces Expanded Use of Cancer Diagnostic in Europe
FURTHER INFORMATION
 
 
 

Related Product News

Bio-Rad Joins EMBL’s Corporate Partnership Programme

Product News

Bio-Rad has announced that it has joined the European Molecular Biology Laboratory (EMBL) Corporate Partnership Programme, to help expand EMBL’s portfolio of scientific training courses designed for budding young scientists.

READ MORE

Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies

Product News

A new company aims to modulate γd T-cell activity using therapeutic antibodies, with the potential to trigger an immune response against cancer.

READ MORE

Tumor Regression with New Antibody-Drug Conjugate

Product News

Iksuda Therapeutics (Iksuda), a developer of next generation Antibody Drug Conjugates (ADCs), has announced the first data on its lead ADC, IKS01.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE